We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ingestible Micro-Robot Wirelessly Navigates Stomach for Remote Diagnosis of GI Tract

By HospiMedica International staff writers
Posted on 15 Jul 2024

Four out of five upper endoscopies typically result in negative outcomes, indicating no medical issues within the patient's stomach that require treatment. More...

Now, an ingestible micro-robot designed to wirelessly navigate the human stomach offers a breakthrough in gastrointestinal (GI) care.

Endiatx (Hayward, CA, USA) has launched PillBot, a revolutionary micro-robot designed to navigate the human stomach, offering a non-invasive, cost-effective alternative for GI diagnostics and treatment. Roughly the size of a vitamin pill, PillBot provides live video feedback as it moves through the water-filled stomach. After a patient ingests water and swallows the PillBot, a physician can remotely control the device using an internet-connected game controller to conduct a comprehensive scan of the stomach. This innovative approach reduces the need for more invasive procedures, lowers costs, and improves accessibility of GI diagnostic and treatment services. PillBot aims to spare many patients the discomfort associated with sedation and hospital visits, while also offering insurers a more economical option. Additionally, this device could help optimize hospital resources by identifying cases that require further investigation following an initial PillBot examination.

Endiatx plans to seek FDA clearance for PillBot following the completion of its clinical trials later this year, with a projected commercial launch in the U.S. by early 2026 and subsequent expansion into international markets, especially in developing countries where GI medical resources are scarce. The ongoing clinical trials have yielded promising results, demonstrating PillBot’s effectiveness and safety in practical applications. Going forward, Endiatx is exploring the integration of artificial intelligence (AI) technology into PillBot to enhance its diagnostic capabilities, potentially enabling routine screenings and acute care diagnostics. Such advancements could improve the early detection of conditions like stomach cancer, which is responsible for nearly 800,000 deaths worldwide annually. An AI-enhanced PillBot would autonomously navigate the stomach, analyze data, and deliver precise diagnostics, thus streamlining and improving the efficiency of GI care.

Related Links:
Endiatx


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.